These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 12445030

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nicotine metabolism and CYP2A6 allele frequencies in Koreans.
    Kwon JT, Nakajima M, Chai S, Yom YK, Kim HK, Yamazaki H, Sohn DR, Yamamoto T, Kuroiwa Y, Yokoi T.
    Pharmacogenetics; 2001 Jun; 11(4):317-23. PubMed ID: 11434509
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A novel polymorphism of human CYP2A6 gene CYP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivo.
    Fukami T, Nakajima M, Yoshida R, Tsuchiya Y, Fujiki Y, Katoh M, McLeod HL, Yokoi T.
    Clin Pharmacol Ther; 2004 Dec; 76(6):519-27. PubMed ID: 15592323
    [Abstract] [Full Text] [Related]

  • 6. Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations.
    Nakajima M, Fukami T, Yamanaka H, Higashi E, Sakai H, Yoshida R, Kwon JT, McLeod HL, Yokoi T.
    Clin Pharmacol Ther; 2006 Sep; 80(3):282-97. PubMed ID: 16952495
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele.
    Fukami T, Nakajima M, Sakai H, McLeod HL, Yokoi T.
    Pharmacogenomics J; 2006 Sep; 6(6):401-12. PubMed ID: 16636685
    [Abstract] [Full Text] [Related]

  • 10. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.
    Nakajima M, Kwon JT, Tanaka N, Zenta T, Yamamoto Y, Yamamoto H, Yamazaki H, Yamamoto T, Kuroiwa Y, Yokoi T.
    Clin Pharmacol Ther; 2001 Jan; 69(1):72-8. PubMed ID: 11180041
    [Abstract] [Full Text] [Related]

  • 11. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
    Benowitz NL, Swan GE, Jacob P, Lessov-Schlaggar CN, Tyndale RF.
    Clin Pharmacol Ther; 2006 Nov; 80(5):457-67. PubMed ID: 17112802
    [Abstract] [Full Text] [Related]

  • 12. Characterization of novel CYP2A6 polymorphic alleles (CYP2A6*18 and CYP2A6*19) that affect enzymatic activity.
    Fukami T, Nakajima M, Higashi E, Yamanaka H, Sakai H, McLeod HL, Yokoi T.
    Drug Metab Dispos; 2005 Aug; 33(8):1202-10. PubMed ID: 15900015
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A novel CYP2A6*20 allele found in African-American population produces a truncated protein lacking enzymatic activity.
    Fukami T, Nakajima M, Higashi E, Yamanaka H, McLeod HL, Yokoi T.
    Biochem Pharmacol; 2005 Sep 01; 70(5):801-8. PubMed ID: 15993850
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A meta-analytic review of the CYP2A6 genotype and smoking behavior.
    Carter B, Long T, Cinciripini P.
    Nicotine Tob Res; 2004 Apr 01; 6(2):221-7. PubMed ID: 15203795
    [Abstract] [Full Text] [Related]

  • 19. Association of CYP2A6*1B genetic variant with the amount of smoking in French adults from the Stanislas cohort.
    Gambier N, Batt AM, Marie B, Pfister M, Siest G, Visvikis-Siest S.
    Pharmacogenomics J; 2005 Apr 01; 5(4):271-5. PubMed ID: 15940289
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.